Addex Therapeutics Ltd ADR (ADXN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Sales | 541 | 620 | 424 | 190 | 257 |
| Gross Profit | 541 | 620 | 424 | 190 | 257 |
| Operating Expenses | 3,135 | 4,225 | 4,737 | 7,535 | 6,497 |
| Operating Income | -2,593 | -3,605 | -4,313 | -7,345 | -6,240 |
| Interest Expense | 34 | 186 | -58 | 134 | 66 |
| Other Income | 26 | 27 | 4 | 0 | 0 |
| Pre-tax Income | -2,601 | -3,764 | -4,252 | -7,478 | -6,307 |
| Net Income Continuous | -2,601 | -3,764 | -4,252 | -7,478 | -6,307 |
| Net Income | $-2,601 | $-3,764 | $-4,252 | $-7,478 | $-6,307 |
| EPS Basic Total Ops | -5.18 | -3.56 | -11.18 | -23.61 | -19.49 |
| EPS Basic Continuous Ops | -5.10 | -3.30 | -10.68 | -23.95 | -19.97 |
| EPS Diluted Total Ops | -5.18 | -3.56 | -11.18 | -23.61 | -19.49 |
| EPS Diluted Continuous Ops | -5.10 | -3.30 | -10.68 | -23.95 | -19.97 |
| EPS Diluted Before Non-Recurring Items | -5.20 | -5.00 | -11.20 | N/A | N/A |
| EBITDA(a) | $-2,511 | $-3,523 | $-5,819 | $-5,676 | $-6,146 |